Exact Sciences Corp (NASDAQ: EXAS) kicked off on Friday, down -1.06% from the previous trading day, before settling in for the closing price of $67.75. Over the past 52 weeks, EXAS has traded in a range of $38.81-$72.81.
Annual sales at Healthcare sector company slipped by -54.24% over the past five years. While this was happening, its average annual earnings per share was recorded 87.43%. With a float of $186.94 million, this company’s outstanding shares have now reached $189.45 million.
Exact Sciences Corp (EXAS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Exact Sciences Corp is 1.33%, while institutional ownership is 94.18%. The most recent insider transaction that took place on Nov 04 ’25, was worth 105,120. In this transaction SVP, General Counsel & Sec of this company sold 1,500 shares at a rate of $70.08, taking the stock ownership to the 12,585 shares. Before that another transaction happened on Nov 04 ’25, when Company’s EVP, GM, Precision Oncology sold 2,858 for $70.08, making the entire transaction worth $200,289. This insider now owns 22,368 shares in total.
Exact Sciences Corp (EXAS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.06 earnings per share (EPS), higher than consensus estimate (set at -0.19) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
Exact Sciences Corp (NASDAQ: EXAS) Trading Performance Indicators
Take a look at Exact Sciences Corp’s (EXAS) current performance indicators. Last quarter, stock had a quick ratio of 2.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.12. Likewise, its price to free cash flow for the trailing twelve months is 51.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.32, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach 0.31 in one year’s time.
Technical Analysis of Exact Sciences Corp (EXAS)
Exact Sciences Corp (NASDAQ: EXAS) saw its 5-day average volume 2.33 million, a negative change from its year-to-date volume of 2.74 million. As of the previous 9 days, the stock’s Stochastic %D was 41.95%.
During the past 100 days, Exact Sciences Corp’s (EXAS) raw stochastic average was set at 83.00%, which indicates a significant increase from 44.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.30 in the past 14 days, which was higher than the 1.85 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.84, while its 200-day Moving Average is $52.05. Nevertheless, the first resistance level for the watch stands at $68.33 in the near term. At $69.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $70.98. If the price goes on to break the first support level at $65.67, it is likely to go to the next support level at $64.31. The third support level lies at $63.01 if the price breaches the second support level.
Exact Sciences Corp (NASDAQ: EXAS) Key Stats
The company with the Market Capitalisation of 12.70 billion has total of 189,471K Shares Outstanding. Its annual sales at the moment are 2,759 M in contrast with the sum of -1,029 M annual income. Company’s last quarter sales were recorded 850,740 K and last quarter income was -19,590 K.
